Protagenic Therapeutics, Inc. (PTIX)

Protagenic Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Year	2023	2022	2021	2020	2019
Cash & Equivalents	1.29	0.22	0.54	0.67	0.8
Short-Term Investments	2.77	7.76	9.83	0	0
Cash & Cash Equivalents	4.06	7.98	10.37	0.67	0.8
Cash Growth	-49.16%	-23.07%	1445.43%	-15.97%	30.31%
Other Current Assets	0.14	0.06	0.69	0.21	0.04
Total Current Assets	4.2	8.04	11.06	0.88	0.84
Property, Plant & Equipment	0.12	0	0	0	0
Total Long-Term Assets	0.12	0	0	0	0
Total Assets	4.32	8.04	11.06	0.88	0.84
Accounts Payable	0.66	0.78	0.8	0.57	0.87
Current Debt	0	0.34	0	0	0
Other Current Liabilities	0	0	0	0.08	0.33
Total Current Liabilities	0.66	1.12	0.8	0.66	1.2
Long-Term Debt	0	0	0.32	1.37	0.28
Total Long-Term Liabilities	0	0	0.32	1.37	0.28
Total Liabilities	0.66	1.12	1.12	2.03	1.48
Total Debt	0	0.34	0.32	1.37	0.28
Debt Growth	-	8.10%	-76.82%	391.75%	-
Retained Earnings	-30.78	-25.78	-22.22	-17.7	-15.15
Comprehensive Income	-0.11	-0.68	-0.25	-0.17	-0.17
Shareholders' Equity	3.67	6.92	9.94	-1.15	-0.63
Net Cash / Debt	4.06	7.63	10.05	-0.7	0.52
Net Cash / Debt Growth	-46.87%	-24.06%	-	-	-15.28%
Net Cash Per Share	0.93	1.77	2.73	-0.27	0.20
Working Capital	3.54	6.92	10.26	0.22	-0.36
Book Value Per Share	0.84	1.60	2.70	-0.45	-0.25

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).